Influenza virus vaccine live/paracetamol

Influenza virus vaccine live/paracetamol Reactions 1680, p179 - 2 Dec 2017 Influenza virus vaccine live/ paracetamol Anaphylaxis, syncope and Stevens‐Johnson syndrome: 3 case reports In a study to evaluate the safety of live attenuated influenza vaccine, 3 patients were described [sexes not stated; not all ages stated], of whom one patient patient developed Stevens‐Johnson syndrome following treatment with paracetamol [acetaminophen], one patient developed syncope and a 3-year-old patient developed anaphylaxis following treatment with influenza virus vaccine live [routes and dosages not stated; not all times to reaction onsets and outcomes stated]. Case 1: One patient received paracetamol, concurrently with influenza virus vaccine live. However, following paracetamol administration, the patient developed Stevens‐Johnson syndrome that was considered to be caused by paracetamol. Case 2: One patient received treatment with influenza virus vaccine live. However, within few minutes of the influenza- virus vaccine live administration, the patient developed treatment-related syncope. Case 3: A 3‐ year‐old patient received treatment with influenza virus vaccine live. However, after 2 hours of the vaccination, the patient developed anaphylaxis with symptoms of wheezing, lip swelling and hives, which were considered to be treatment-related. Though a history of egg allergy was noted, the patient had received injectable influenza vaccine in the past without an allergic reaction. Eventually, the patient’s anaphylaxis had completely recovered. Author comment: "One case of Stevens‐Johnson syndrome occurred in the risk period following [influenza- virus vaccine live]: acetaminophen was considered the cause, although the subject had also been exposed to LAIV preceding development of Stevens‐Johnson syndrome." "One confirmed syncope case occurred in an individual who received LAIV and no other vaccines". "One case of anaphylaxis occurred in the risk window. . .2 hours after receiving LAIV." Daley MF, et al. The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study. Pharmacoepidemiology and Drug Safety : 17 Nov 2017. Available from: URL: http://doi.org/10.1002/pds.4349 - USA 803284286 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Influenza virus vaccine live/paracetamol

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page
Loading next page...
1 Page
 
/lp/springer_journal/influenza-virus-vaccine-live-paracetamol-QXWB4z9YPi
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39110-8
Publisher site
See Article on Publisher Site

Abstract

Reactions 1680, p179 - 2 Dec 2017 Influenza virus vaccine live/ paracetamol Anaphylaxis, syncope and Stevens‐Johnson syndrome: 3 case reports In a study to evaluate the safety of live attenuated influenza vaccine, 3 patients were described [sexes not stated; not all ages stated], of whom one patient patient developed Stevens‐Johnson syndrome following treatment with paracetamol [acetaminophen], one patient developed syncope and a 3-year-old patient developed anaphylaxis following treatment with influenza virus vaccine live [routes and dosages not stated; not all times to reaction onsets and outcomes stated]. Case 1: One patient received paracetamol, concurrently with influenza virus vaccine live. However, following paracetamol administration, the patient developed Stevens‐Johnson syndrome that was considered to be caused by paracetamol. Case 2: One patient received treatment with influenza virus vaccine live. However, within few minutes of the influenza- virus vaccine live administration, the patient developed treatment-related syncope. Case 3: A 3‐ year‐old patient received treatment with influenza virus vaccine live. However, after 2 hours of the vaccination, the patient developed anaphylaxis with symptoms of wheezing, lip swelling and hives, which were considered to be treatment-related. Though a history of egg allergy was noted, the patient had received injectable influenza vaccine in the past without an allergic reaction. Eventually, the patient’s anaphylaxis had completely recovered. Author comment: "One case of Stevens‐Johnson syndrome occurred in the risk period following [influenza- virus vaccine live]: acetaminophen was considered the cause, although the subject had also been exposed to LAIV preceding development of Stevens‐Johnson syndrome." "One confirmed syncope case occurred in an individual who received LAIV and no other vaccines". "One case of anaphylaxis occurred in the risk window. . .2 hours after receiving LAIV." Daley MF, et al. The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: A Vaccine Safety Datalink study. Pharmacoepidemiology and Drug Safety : 17 Nov 2017. Available from: URL: http://doi.org/10.1002/pds.4349 - USA 803284286 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680

Journal

Reactions WeeklySpringer Journals

Published: Dec 2, 2017

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off